TY - JOUR
T1 - Lens-specific expression of a major histocompatibility complex class I molecule disrupts normal lens development and induces cataracts in transgenic mice
AU - Martin, W. D.
AU - Egan, R. M.
AU - Stevens, J. L.
AU - Woodward, J. G.
PY - 1995
Y1 - 1995
N2 - Purpose. Lens epithelial tissue does not normally express major histocompatibility complex (MHC) class I molecules. In addition, the mechanism of self-tolerance to intraocular antigens is unknown. To study the effect of class I expression in the lens, transgenic mice were produced that express an allo-MHC class I molecule under the αA-crystallin proximal promoter. Methods. pαD(d) was generated by fusion of the H-2D(d) structural gent to the αA-crystallin proximal promoter. Transgenic mice were produced, and founder lines were identified by Southern blot hybridization. Eyes from transgenic mice were cryostat sectioned and stained for D(d) expression or fixed in paraformaldehyde and stained for histologic analysis. Lens RNA was isolated by acid phenol extraction, and transgenic expression was analyzed by nuclease protection. Results. The transgenic mice demonstrated dose- dependent, nonimmunologic lens defects consistent within a given line. In the highest expressing lines, ocular defects, including microphthalmia and cataract formation, were observed. Many adult mice from these lines demonstrated lens capsule rupture and a D(d)-specific inflammatory response. Inflammation did not occur in mice with intact lens capsules. Conclusions. Overexpression of H-2D(d) in the lens had serious nonimmunologic consequences on lens development and cataract formation. In addition, the high copy number mice revealed at least a partial loss of immunologic tolerance on lens capsule rupture. The lack of an inflammatory response in transgenic mice with intact lens capsules suggests that the physical barrier of the lens capsule is one mechanism of maintaining immune privilege.
AB - Purpose. Lens epithelial tissue does not normally express major histocompatibility complex (MHC) class I molecules. In addition, the mechanism of self-tolerance to intraocular antigens is unknown. To study the effect of class I expression in the lens, transgenic mice were produced that express an allo-MHC class I molecule under the αA-crystallin proximal promoter. Methods. pαD(d) was generated by fusion of the H-2D(d) structural gent to the αA-crystallin proximal promoter. Transgenic mice were produced, and founder lines were identified by Southern blot hybridization. Eyes from transgenic mice were cryostat sectioned and stained for D(d) expression or fixed in paraformaldehyde and stained for histologic analysis. Lens RNA was isolated by acid phenol extraction, and transgenic expression was analyzed by nuclease protection. Results. The transgenic mice demonstrated dose- dependent, nonimmunologic lens defects consistent within a given line. In the highest expressing lines, ocular defects, including microphthalmia and cataract formation, were observed. Many adult mice from these lines demonstrated lens capsule rupture and a D(d)-specific inflammatory response. Inflammation did not occur in mice with intact lens capsules. Conclusions. Overexpression of H-2D(d) in the lens had serious nonimmunologic consequences on lens development and cataract formation. In addition, the high copy number mice revealed at least a partial loss of immunologic tolerance on lens capsule rupture. The lack of an inflammatory response in transgenic mice with intact lens capsules suggests that the physical barrier of the lens capsule is one mechanism of maintaining immune privilege.
KW - cataract models (C-10)
KW - immune privilege (I-5)
KW - immunocytochemistry (I- 7)
KW - tolerance (T-7)
KW - transgenic animals (T-17)
UR - http://www.scopus.com/inward/record.url?scp=0028905515&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028905515&partnerID=8YFLogxK
M3 - Article
C2 - 7537260
AN - SCOPUS:0028905515
SN - 0146-0404
VL - 36
SP - 1144
EP - 1154
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 6
ER -